Enhancing prolonged exposure therapy for PTSD among veterans with oxytocin: Design of a multisite randomized controlled trial

Posttraumatic stress disorder (PTSD) is the most highly prevalent mental health disorder among U.S. military Veterans. Prolonged Exposure (PE) therapy is one of the most widely used evidence-based treatments for PTSD, but there is substantial room for improvement in outcomes and retention rates. Accumulating data suggest that oxytocin offers a promising pharmacological approach towards achieving this goal. Therefore, the primary objective of this two-site Phase II study is to examine the ability of oxytocin (vs.

Source: Contemporary Clinical Trials - June 15, 2020 Category: Radiology Authors: Julianne C. Flanagan, Jennifer M. Mitchell, Nathaniel L. Baker, Joshua Woolley, Bethany Wangelin, Sudie E. Back, John R. McQuaid, Thomas C. Neylan, William R. Woolfe, Kathleen T. Brady Source Type: research